Japan Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Japan Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices


  • Products Id :- GDMEMC0251DB
  • |
  • Pages: 122
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Japan Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices

Summary

GlobalData's new report, "Japan Drug Delivery Devices Market Outlook to 2023", provides key market data on the Japan Drug Delivery Devices market. The report provides value, in millions of US dollars and volume (in units) within market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

Market size and company share data for Drug Delivery Devices market categories-Central Venous Catheters, Needle Free Injections, Infusion Systems and Metered Dose Inhaler Devices.

Annualized market revenues (USD million) and volume (units) data for each of the market categories. Data is provided from 2009 to 2016 and forecast to 2023.

2016 company shares and distribution shares data for each of the market categories.

Global corporate-level profiles of key companies operating within the Japan Drug Delivery Devices market.

Key players covered include GlaxoSmithKline Plc, AstraZeneca Plc, Hospira Inc, Becton Dickinson and Co, Boehringer Ingelheim GmbH, Baxter International Inc, Medtronic plc and others.

Reasons to buy

Develop business strategies by identifying the key market categories poised for strong growth in the future.

Develop market-entry and market expansion strategies.

Design competition strategies by identifying who-stands-where in the market.

Develop investment strategies by identifying the key market categories expected to register strong growth in the near future.

What are the key distribution channels and what's the most preferred mode of product distribution-Identify, understand and capitalize.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 What Is This Report About? 7

2.2 Drug Delivery Devices Market Segmentation 7

2.3 Definitions of Markets Covered in the Report 8

3 Drug Delivery Devices Market, Japan 11

3.1 Drug Delivery Devices Market, Japan, Revenue ($m), 2009-2023 11

3.2 Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2016 13

3.3 Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2016 14

3.4 Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023 15

3.5 Drug Delivery Devices Market, Japan, Revenue ($m), 2009-2016 17

3.6 Drug Delivery Devices Market, Japan, Revenue ($m), 2016-2023 19

3.7 Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023 21

3.8 Drug Delivery Devices Market, Japan, Volume (Units), 2009-2016 23

3.9 Drug Delivery Devices Market, Japan, Volume (Units), 2016-2023 25

3.10 Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), 2016 27

4 Central Venous Catheters Market, Japan 29

4.1 Central Venous Catheters Market, Japan, Revenue Mix ($m), 2016 29

4.2 Central Venous Catheters Market, Japan, Segment Contribution (%), 2016 30

4.3 Central Venous Catheters Market, India, Revenue ($m), 2009-2016 31

4.4 Central Venous Catheters Market, India, Revenue ($m), 2016-2023 33

4.5 Central Venous Catheters Market, India, Volume (Units), 2009-2016 35

4.6 Central Venous Catheters Market, India, Volume (Units), 2016-2023 37

4.7 Central Venous Catheters Market, India, Distribution Share by Revenue ($m), 2015-2016 39

4.8 Central Venous Catheters Market, India, Company Share by Revenue ($m), 2016 40

5 Infusion Systems Market, Japan 42

5.1 Infusion Systems Market, Japan, Revenue Mix ($m), 2016 42

5.2 Infusion Systems Market, Japan, Segment Contribution (%), 2016 43

5.3 Infusion Systems Market, Japan, Revenue ($m), 2009-2016 44

5.4 Infusion Systems Market, Japan, Revenue ($m), 2016-2023 46

5.4.1 Ambulatory Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2009-2016 48

5.4.2 Syringe Pumps Market, Japan, Revenue ($m), by Segment, 2009-2016 50

5.4.3 Ambulatory Infusion Pumps Market, Japan, Revenue ($m), by Segment, 2016-2023 52

5.4.4 Syringe Pumps Market, Japan, Revenue ($m), by Segment, 2016-2023 54

5.5 Infusion Systems Market, Japan, Volume (Units), 2009-2016 56

5.6 Infusion Systems Market, Japan, Volume (Units), 2016-2023 58

5.6.1 Ambulatory Infusion Pumps Market, Japan, Volume (Units), by Segment, 2009-2016 60

5.6.2 Syringe Pumps Market, Japan, Volume (Units), by Segment, 2009-2016 62

5.6.3 Ambulatory Infusion Pumps Market, Japan, Volume (Units), by Segment, 2016-2023 64

5.6.4 Syringe Pumps Market, Japan, Volume (Units), by Segment, 2016-2023 66

5.7 Infusion Systems Market, Japan, Distribution Share by Revenue ($m), 2015-2016 68

5.8 Infusion Systems Market, Japan, Company Share by Revenue ($m), 2016 69

6 Needle Free Injections Market, Japan 71

6.1 Needle Free Injections Market, Japan, Revenue ($m), 2009-2016 71

6.2 Needle Free Injections Market, Japan, Revenue ($m), 2016-2023 72

6.3 Needle Free Injections Market, Japan, Volume (Units), 2009-2016 73

6.4 Needle Free Injections Market, Japan, Volume (Units), 2016-2023 74

6.5 Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), 2015-2016 75

6.6 Needle Free Injections Market, Japan, Company Share by Revenue ($m), 2016 76

7 Metered Dose Inhaler Devices Market, Japan 78

7.1 Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2009-2016 78

7.2 Metered Dose Inhaler Devices Market, Japan, Revenue ($m), 2016-2023 79

7.3 Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2009-2016 80

7.4 Metered Dose Inhaler Devices Market, Japan, Volume (Units), 2016-2023 81

7.5 Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), 2015-2016 82

7.6 Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), 2016 83

8 Overview of Key Companies in Japan, Drug Delivery Devices Market 85

8.1 Terumo Corp 85

8.1.1 Company Overview 85

8.2 GlaxoSmithKline Plc 85

8.2.1 Company Overview 85

8.3 Teleflex Inc 85

8.3.1 Company Overview 85

8.4 AstraZeneca Plc 85

8.4.1 Company Overview 85

8.5 Boehringer Ingelheim GmbH 86

8.5.1 Company Overview 86

8.6 Pfizer Inc 86

8.6.1 Company Overview 86

8.7 Merck & Co Inc 86

8.7.1 Company Overview 86

8.8 B. Braun Melsungen AG 86

8.8.1 Company Overview 86

8.9 Nipro Corp 87

8.9.1 Company Overview 87

8.10 Baxter International Inc 87

8.10.1 Company Overview 87

8.11 Smiths Medical 87

8.11.1 Company Overview 87

8.12 Becton Dickinson and Co 87

8.12.1 Company Overview 87

8.13 Hospira Inc 88

8.13.1 Company Overview 88

8.14 Fresenius Kabi AG 88

8.14.1 Company Overview 88

8.15 Medtronic plc 88

8.15.1 Company Overview 88

9 Drug Delivery Devices Market Pipeline Products 89

10 Financial Deals Landscape 94

10.1 Asset Transactions 94

10.1.1 ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94

10.2 Equity Offerings 96

10.2.1 Solasia Pharma to Raise USD31.9 Million in IPO 96

10.3 Partnerships 98

10.3.1 Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 98

10.3.2 Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 99

10.3.3 Terumo to Enter into Agreement with Phosphagenics 101

10.3.4 Pfizer Terminates its Licensing Agreement with pSivida 102

10.3.5 Bayer Enters into Licensing Agreement with DelSiTech 103

10.3.6 BioCorRx Enters into Licensing Agreement with Therakine 104

11 Recent Developments 105

11.1 Corporate Communications 105

11.1.1 Jun 16, 2017: Sumitomo Dainippon Pharma announces personnel change 105

11.1.2 May 08, 2017: Sumitomo Dainippon Pharma announces personnel change 105

11.1.3 Mar 29, 2017: Sumitomo Dainippon Pharma announces Changes in Executive Officers 105

11.1.4 Mar 22, 2017: Sumitomo Dainippon Pharma Announces New Chief Executive Officer at Boston Biomedical and Establishment of Global Head of Oncology 105

11.1.5 Feb 24, 2017: Daiichi Sankyo Appoints New Group Corporate Officers 106

11.1.6 Feb 24, 2017: Sumitomo Dainippon Pharma announces Changes of Representative Directors and Executive Officers 107

11.1.7 Feb 09, 2017: Terumo Announces Change of Executive Officers 107

11.1.8 Jan 31, 2017: Daiichi Sankyo Announces New Chairman and President 108

11.1.9 Nov 11, 2016: Sumitomo Dainippon Pharma Announces Organizational Realignment and Changes Related to Officers and Other Key Positions 108

11.1.10 Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development 109

11.2 Financial Announcements 109

11.2.1 Jul 29, 2016: Summary of Consolidated Financial Results For the First Quarter of the Fiscal Year Ending March 31, 2017 109

11.3 Government and Public Interest 111

11.3.1 Jul 11, 2017: Daiichi Sankyo Selected for Ninth Consecutive Year as Constituent of FTSE4Good Global Index by FTSE Russell 111

11.3.2 Jul 03, 2017: 15th Takamine Memorial Daiichi Sankyo Prize Winner Announced 111

11.4 Legal And Regulatory 112

11.4.1 Jul 04, 2017: Sumitomo Dainippon Pharma Announces Change in Name of Consolidated Subsidiary Based in U.S. 112

11.5 Other Significant Developments 112

11.5.1 Apr 27, 2017: Daiichi Sankyo Announces 15 Billion Yen Manufacturing Investment to Support Acceleration of Antibody Drug Conjugate Portfolio 112

11.5.2 Jan 26, 2017: Achievement of sales milestone for COPD products 113

11.5.3 Jan 10, 2017: Daiichi Sankyo Announces Reorganization of Research & Development System 113

11.5.4 Dec 12, 2016: Terumo Formulates 5-Year Mid- to Long-term Growth Strategy 113

11.6 Product News 114

11.6.1 Jun 12, 2017: Aptar Pharma Extends its Child-Resistant Nasal Pump Manufacturing Capabilities in North America 114

11.6.2 Jan 30, 2017: Terumo launches user friendly PLAJEX Luer Lock with Threaded Closure (TC) 114

11.6.3 Jan 26, 2017: Terumo and Nemera announce compatibility between PLAJEX polymer prefillable syringes and Safe'n'Sound 114

11.7 Strategy And Business Planning 115

11.7.1 Feb 24, 2017: Daiichi Sankyo Announces Organizational Restructuring Effective as of April 1, 2017 115

11.7.2 Feb 15, 2017: Daiichi Sankyo Strengthens Authorized Generic Business through Daiichi Sankyo Espha 116

11.7.3 Feb 10, 2017: Daiichi Sankyo Announces Further Reorganization of its Research & Development Structure 116

11.7.4 Jan 31, 2017: Terumo Opens a Branch in Yangon 117

12 Appendix 118

12.1 Research Methodology 119

12.1.1 Coverage 119

12.1.2 Secondary Research 119

12.1.3 Primary Research 120

12.1.4 Company Share Analysis 120

12.1.5 Distribution Share Analysis 120

12.1.6 Benchmarking 121

12.2 GlobalData Consulting 121

12.3 Contact Us 122

12.4 Disclaimer 122

1.2 List of Figures

Figure 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2009-2023 11

Figure 2: Drug Delivery Devices Market, Japan, Revenue Mix ($m), 2016 13

Figure 3: Drug Delivery Devices Market, Japan, Category Contribution (%), 2016 14

Figure 4: Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023 15

Figure 5: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 17

Figure 6: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 19

Figure 7: Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023 21

Figure 8: Drug Delivery Devices Market, Japan, Volume (Units), Historic, 2009-2016 23

Figure 9: Drug Delivery Devices Market, Japan, Volume (Units), Forecast, 2016-2023 25

Figure 10: Drug Delivery Devices Market, Japan, Company Share (%) 2016 27

Figure 11: Central Venous Catheters Market, Japan, Revenue Mix ($m), 2016 29

Figure 12: Central Venous Catheters Market, Japan, Segment Contribution (%), 2016 30

Figure 13: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 31

Figure 14: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 33

Figure 15: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 35

Figure 16: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 37

Figure 17: Central Venous Catheters Market, India, Company Share (%) 2016 40

Figure 18: Infusion Systems Market, Japan, Revenue Mix ($m), 2016 42

Figure 19: Infusion Systems Market, Japan, Segment Contribution (%), 2016 43

Figure 20: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 44

Figure 21: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 46

Figure 22: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 48

Figure 23: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 50

Figure 24: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 52

Figure 25: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 54

Figure 26: Infusion Systems Market, Japan, Volume (Units), Historic, 2009-2016 56

Figure 27: Infusion Systems Market, Japan, Volume (Units), Forecast, 2016-2023 58

Figure 28: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Historic, 2009-2016 60

Figure 29: Syringe Pumps Market, Japan, Volume (Units), Historic, 2009-2016 62

Figure 30: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Forecast, 2016-2023 64

Figure 31: Syringe Pumps Market, Japan, Volume (Units), Forecast, 2016-2023 66

Figure 32: Infusion Systems Market, Japan, Company Share (%) 2016 69

Figure 33: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 71

Figure 34: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 72

Figure 35: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016 73

Figure 36: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023 74

Figure 37: Needle Free Injections Market, Japan, Company Share (%) 2016 76

Figure 38: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 78

Figure 39: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 79

Figure 40: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016 80

Figure 41: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023 81

Figure 42: Metered Dose Inhaler Devices Market, Japan, Company Share (%) 2016 83

1.1 List of Tables

Table 1: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, 2009-2023 12

Table 2: Drug Delivery Devices Market, Japan, Category Contribution by Revenue ($m), 2016 14

Table 3: Drug Delivery Devices Market, Japan, Category Comparison by Revenue ($m), 2009-2023 16

Table 4: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 18

Table 5: Drug Delivery Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 20

Table 6: Drug Delivery Devices Market, Japan, Volume (Units), 2009-2023 22

Table 7: Drug Delivery Devices Market, Japan, Volume (Units), Historic, 2009-2016 24

Table 8: Drug Delivery Devices Market, Japan, Volume (Units), Forecast, 2016-2023 26

Table 9: Drug Delivery Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 28

Table 10: Central Venous Catheters Market, Japan, Segment Contribution (%), 2016 30

Table 11: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Historic, 2009-2016 32

Table 12: Central Venous Catheters Market, India, Revenue ($m), USD Constant, Forecast, 2016-2023 34

Table 13: Central Venous Catheters Market, India, Volume (Units), Historic, 2009-2016 36

Table 14: Central Venous Catheters Market, India, Volume (Units), Forecast, 2016-2023 38

Table 15: Central Venous Catheters Market, India, Distribution Share by Revenue ($m), USD Constant, 2015-2016 39

Table 16: Central Venous Catheters Market, India, Company Share by Revenue ($m), USD Constant, 2016 41

Table 17: Infusion Systems Market, Japan, Segment Contribution (%), 2016 43

Table 18: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 45

Table 19: Infusion Systems Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 47

Table 20: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 49

Table 21: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 51

Table 22: Ambulatory Infusion Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 53

Table 23: Syringe Pumps Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 55

Table 24: Infusion Systems Market, Japan, Volume (Units), Historic, 2009-2016 57

Table 25: Infusion Systems Market, Japan, Volume (Units), Forecast, 2016-2023 59

Table 26: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Historic, 2009-2016 61

Table 27: Syringe Pumps Market, Japan, Volume (Units), Historic, 2009-2016 63

Table 28: Ambulatory Infusion Pumps Market, Japan, Volume (Units), Forecast, 2016-2023 65

Table 29: Syringe Pumps Market, Japan, Volume (Units), Forecast, 2016-2023 67

Table 30: Infusion Systems Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 68

Table 31: Infusion Systems Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 70

Table 32: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 71

Table 33: Needle Free Injections Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 72

Table 34: Needle Free Injections Market, Japan, Volume (Units), Historic, 2009-2016 73

Table 35: Needle Free Injections Market, Japan, Volume (Units), Forecast, 2016-2023 74

Table 36: Needle Free Injections Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 75

Table 37: Needle Free Injections Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 77

Table 38: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Historic, 2009-2016 78

Table 39: Metered Dose Inhaler Devices Market, Japan, Revenue ($m), USD Constant, Forecast, 2016-2023 79

Table 40: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Historic, 2009-2016 80

Table 41: Metered Dose Inhaler Devices Market, Japan, Volume (Units), Forecast, 2016-2023 81

Table 42: Metered Dose Inhaler Devices Market, Japan, Distribution Share by Revenue ($m), USD Constant, 2015-2016 82

Table 43: Metered Dose Inhaler Devices Market, Japan, Company Share by Revenue ($m), USD Constant, 2016 84

Table 44: Drug Delivery Devices Market Pipeline Products 89

Table 45: ICU Medical Acquires Hospira Infusion Systems Business from Pfizer 94

Table 46: Solasia Pharma to Raise USD31.9 Million in IPO 96

Table 47: Aequus Pharma to Enter into Licensing Agreement with Transdermal Research Pharm Labs 98

Table 48: Valeant Pharma Enters into Licensing Agreement with EyeGate Pharma 99

Table 49: Terumo to Enter into Agreement with Phosphagenics 101

Table 50: Pfizer Terminates its Licensing Agreement with pSivida 102

Table 51: Bayer Enters into Licensing Agreement with DelSiTech 103

Table 52: BioCorRx Enters into Licensing Agreement with Therakine 104

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Terumo Corp

GlaxoSmithKline Plc

Teleflex Inc

AstraZeneca Plc

Boehringer Ingelheim GmbH

Pfizer Inc

Merck & Co Inc

B. Braun Melsungen AG

Nipro Corp

Baxter International Inc

Smiths Medical

Becton Dickinson and Co

Hospira Inc

Fresenius Kabi AG

Medtronic plc

Drug Delivery Devices, Central Venous Catheters, Needle Free Injections, Infusion Systems, Metered Dose Inhaler Devices, Value (USD), Volume (units), Revenues, Historic Revenues, Forecast Revenues, Average Price, Company Share, Distribution Share by Revenue, Company Share by Revenue, Pipeline Products, News, Deals, Key Companies, GlaxoSmithKline Plc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Pfizer Inc, Merck & Co Inc, Sunovion Pharmaceuticals Inc, Teva Pharmaceutical Industries Ltd, INJEX-Equidyne Systems, Bioject Medical Technologies Inc , Antares Pharma Inc, PharmaJet Inc, MK Global Co., The European Pharma Group, Hospira Inc, Becton Dickinson and Co, Baxter International Inc, Fresenius Kabi AG, Medtronic plc, B. Braun Melsungen AG, Terumo Corp, Smiths Medical, Nipro Corp, JMS Co Ltd

select a license

Single User License
USD 5995 INR 434757
Site License
USD 11990 INR 869515
Corporate User License
USD 17985 INR 1304272

NEWSLETTER BY CATEGORY




Testimonials

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...



Ken Research, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com